Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases

BACKGROUND: Although the clinical efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) in EGFR‐mutant non‐small cell lung cancer (NSCLC) patients has been demonstrated, their efficacy in EGFR‐mutant NSCLCs with central nervous system (CNS) metastases and the role of ra...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thorac Cancer
Autori principali: Saida, Yu, Watanabe, Satoshi, Abe, Tetsuya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Koyama, Kenichi, Miura, Satoru, Tanaka, Hiroshi, Okajima, Masaaki, Terada, Masaki, Ishida, Takashi, Tsukada, Hiroki, Makino, Masato, Iwashima, Akira, Sato, Kazuhiro, Matsumoto, Naoya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons Australia, Ltd 2019
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825912/
https://ncbi.nlm.nih.gov/pubmed/31507098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13189
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi